Literature DB >> 25998522

MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

C Jiang1, X Chen2, M Alattar3, J Wei4, H Liu5.   

Abstract

MicroRNAs (miRNAs), which are small single-stranded RNA molecules composed of 18-23 nucleotides, act as oncogenes or tumor suppressor genes playing important roles in tumor formation, infiltration and metastasis. Subsequently, miRNAs expression contributes to cancer diagnosis and prognosis. Gastric cancer currently has high morbidity and mortality among all malignant tumors, yet it lacks early specific diagnostic markers and effective treatments. In gastric cancer, many studies have detected abnormal expression forms of miRNAs and confirmed their involvement in its tumorigenesis, progression, invasion and metastasis. They may become valuable diagnostic markers and therapeutic targets for gastric cancer. Studying the role of miRNAs in gastric cancer and its relationship with diagnostic and prognostic parameters might help to improve the sensitivity of diagnosis as well as the efficacy of gastric cancer treatment. This review aims to highlight the advancements which might provide new methods for early clinical diagnosis and effective therapeutic options, along with predict response to treatment for gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25998522     DOI: 10.1038/cgt.2015.19

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  132 in total

1.  MiR-9 downregulates CDX2 expression in gastric cancer cells.

Authors:  Pichayanoot Rotkrua; Yoshimitsu Akiyama; Yutaka Hashimoto; Takeshi Otsubo; Yasuhito Yuasa
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

2.  Oncogenic miR-544 is an important molecular target in gastric cancer.

Authors:  Qiaoming Zhi; Xiaobo Guo; Lei Guo; Rongjuan Zhang; Jinling Jiang; Jun Ji; Jianian Zhang; Jun Zhang; Xuehua Chen; Qu Cai; Jianfang Li; Bingya Liu; Zhenggang Zhu; Yingyan Yu
Journal:  Anticancer Agents Med Chem       Date:  2013-02       Impact factor: 2.505

3.  Downregulation of microRNA-200 in EBV-associated gastric carcinoma.

Authors:  Aya Shinozaki; Takashi Sakatani; Tetsuo Ushiku; Rumi Hino; Maya Isogai; Shunpei Ishikawa; Hiroshi Uozaki; Kenzo Takada; Masashi Fukayama
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

4.  Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C.

Authors:  Qiaoyuan Yang; Zhigang Jie; Hong Cao; Anne R Greenlee; Chengfeng Yang; Fei Zou; Yiguo Jiang
Journal:  Carcinogenesis       Date:  2011-02-24       Impact factor: 4.944

5.  MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.

Authors:  Hui-Ju Wang; Hong-Jun Ruan; Xu-Jun He; Ying-Yu Ma; Xiao-Ting Jiang; Ying-Jie Xia; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Eur J Cancer       Date:  2010-08       Impact factor: 9.162

6.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

7.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

8.  Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour.

Authors:  Ya-Wen Wang; Duan-Bo Shi; Xu Chen; Chao Gao; Peng Gao
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

9.  MicroRNA-219-2-3p functions as a tumor suppressor in gastric cancer and is regulated by DNA methylation.

Authors:  Huizi Lei; Dongling Zou; Zheng Li; Min Luo; Lei Dong; Bin Wang; Haixin Yin; Yanni Ma; Changzheng Liu; Fang Wang; Junwu Zhang; Jia Yu; Yu Li
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2).

Authors:  Xiangsheng Li; Zhichao Zhang; Ming Yu; Liqi Li; Guangsheng Du; Weidong Xiao; Hua Yang
Journal:  Int J Mol Sci       Date:  2013-08-06       Impact factor: 5.923

View more
  54 in total

1.  Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.

Authors:  Malcolm Boyce; Andrew R Moore; Liv Sagatun; Bryony N Parsons; Andrea Varro; Fiona Campbell; Reidar Fossmark; Helge L Waldum; D Mark Pritchard
Journal:  Br J Clin Pharmacol       Date:  2016-11-21       Impact factor: 4.335

2.  GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK/STAT signaling pathway.

Authors:  Jun Ouyang; Xiaohui Pan; Hui Lin; Zecheng Hu; Ping Xiao; Haobin Hu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5.

Authors:  Lina Li; Cuiling Wu; Yue Zhao
Journal:  Oncol Lett       Date:  2017-04-18       Impact factor: 2.967

4.  Regulatory mechanism of microRNA-128 in osteosarcoma tumorigenesis and evolution through targeting SASH1.

Authors:  Zi Li; Jiangdong Ni; Deye Song; Muliang Ding
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

5.  MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer.

Authors:  Jinxin Shi; Ping Chen; Jingxu Sun; Yongxi Song; Bin Ma; Peng Gao; Xiaowan Chen; Zhenning Wang
Journal:  Oncol Lett       Date:  2017-03-22       Impact factor: 2.967

6.  MiR-592 represses FOXO3 expression and promotes the proliferation of prostate cancer cells.

Authors:  Zhonghua Lv; Pinlang Rao; Wenlin Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  miRNA-346 promotes proliferation, migration and invasion in liver cancer.

Authors:  Qiang Yu; Xia Yang; Weidong Duan; Chonghui Li; Ying Luo; Shichun Lu
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

8.  MiR-200c suppresses the migration of retinoblastoma cells by reversing epithelial mesenchymal transition.

Authors:  Xiao-Lei Shao; Yao Chen; Ling Gao
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  MicroRNAs in hereditary diffuse gastric cancer.

Authors:  Mayra-Cecilia Suárez-Arriaga; Rosa-María Ribas-Aparicio; Martha-Eugenia Ruiz-Tachiquín
Journal:  Biomed Rep       Date:  2016-06-24

Review 10.  Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.

Authors:  Shan-Shan Xie; Juan Jin; Xiao Xu; Wei Zhuo; Tian-Hua Zhou
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.